Posts Tagged ‘study’

Treatment of Hepatitis C

Posted by • January 19th, 2012

In a new study of 21 patients with hepatitis C virus genotype 1 infection who had had no response to prior treatment, sustained virologic responses were achieved in 4 of 11 who were treated with two antiviral agents alone and in 9 of 10 who were treated with the antiviral agents plus peginterferon and ribavirin. Approximately… Read More…

Hope for Hepatitis C

Posted by • January 18th, 2012

Imagine, for a moment, that you recently received a brand new Time-O-Matic Time Machine as a gift. How far back would you have to set the dial to see that meaningful progress has been made in the treatment of hepatitis C? First, let’s say you set the dial to January 2011 and –- Puff-kachunk! — you’re… Read More…

Rivaroxaban in ACS

Posted by • January 6th, 2012

In a study of patients with acute coronary syndromes, low doses of rivaroxaban were effective in reducing the primary end point of death from cardiovascular causes, myocardial infarction, or stroke. Rivaroxaban also reduced overall mortality, although there was more bleeding.         After an acute coronary syndrome, patients remain at risk for recurrent cardiovascular events despite optimal medical therapy,… Read More…